European Archives - Page 153 of 1271 - European Medical Journal

Blood Test Offers Breakthrough in Heart Disease Treatment

A groundbreaking study has introduced a novel, image-based blood test that could significantly enhance the way doctors manage and personalise treatment for coronary artery disease (CAD), a leading global cause of death.

New Diabetes Risk Model Recommends Personalised Prevention Strategies

New model predicts diabetes risk and recommends personalised prevention, including lifestyle changes or metformin, for diverse populations.

Ulinastatin Reduces Inflammation in Septic Shock Cases

Children with septic shock who received ulinastatin alongside standard therapy showed significantly improved clinical outcomes.

Faecal Calprotectin as a Biomarker for Sepsis Liver Dysfunction

Discover a study that explored the use of faecal calprotectin as a biomarker for sepsis in liver dysfunction. Learn more.

Ultraprocessed Diets Linked to Early Parkinson’s Markers

Long-term consumption of ultraprocessed foods is associated with an increased risk of multiple nonmotor symptoms that often precede a Parkinson’s disease diagnosis.

Knee Osteoarthritis Injections Less Likely with Timely Physical Therapy

Early initiation and consistent physical therapy may help reduce reliance on intra-articular injections for patients with newly diagnosed knee osteoarthritis, according to new real-world data.

Hyperbaric Oxygen Therapy for Radiation-Induced Dermatitis

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

Combined Therapy Reduces Daytime Incontinence in Children

Researchers explored the effectiveness of combining biofeedback training with osteopathic techniques to improve outcomes in children with urinary incontinence.

New Data Expose Depth of UK Childhood Obesity Crisis

Children attending NHS excess weight clinics are overwhelmingly from deprived backgrounds, and often face complex health and developmental challenges.

Do GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients With Obesity?

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.